Skip to content
M

M. Anitha

Publications (5)

Amelogenesis Imperfecta– 3 Cases

M. Anitha, Br. Sathvikalakshmi, A. Feroz Khan & R. Sudharshan · Journal of Advances in Medical and Pharmaceutical Sciences · 2018

Amelogenesis imperfecta (AI) - a hereditary heterogenous disorder causing developmental alterations in the structure of enamel. The Al trait can be transmitted by either autosomal dominant, autosomal recessive, or X-linked modes of inheritance. Genes implicated in autosomal forms...

Open access Research Article 10.9734/JAMPS/2018/39759

Digital Imaging Analysis with Fractal Dimension in Oral Leukoplakia

Ch. Uma Reddy, M. Anitha, A. Feroz, L. Chandrashekar, R. Sudarshan & Vigneswary . · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2017

Introduction: Complex geometric structures can be quantified by fractal analysis by generating a fractal dimension (FD), thus it can also measure the complexity of mucosa such as oral leukoplakia and other potentially malignant disorders. Aim: The study was done to perform the fr...

Open access Research Article 10.9734/AJRIMPS/2017/36744

Antimicrobial Efficacy of Moringa oleifera and Sesbania grandiflora against Streptococcus Mutans and Candida Albicans: An In vitro Study

P. Sivakami, B. Siva, Madhulika Naidu, M. Anitha & A. Vishalini · Asian Journal of Dental Sciences · 2021

AIM: To evaluate the antibacterial and antifungal efficacy of Moringa oleifera and Sesbania grandiflora against S. mutans and C. albicans. Settings and Design: The study design involves an in-vitro study. Subjects and Methods: The microbial strains Streptococcus mutans and Candid...

Open access Research Article

New Ray of Hope in Prognosis-Significance of Clinical, Histopathological and Biological Characteristics among Potentially Malignant Disorders and Oral Cancer– Case Series

G. Sathees Chandramouli, Ch. Uma Reddy, A. Steffina Lydia Jascinth, M. Anitha & B. R. Sathvikalakshmi · International Journal of Medical and Pharmaceutical Case Reports · 2018

Early detection of disease progression remains a challenging task mainly due to the lack of adequate early predictive markers. It is necessary to consider the biological behaviour and underlined molecular events while selecting treatment modalities in order to get the better outc...

Open access Research Article 10.9734/IJMPCR/2018/39111